SUMO2 and glioblastoma: However, SENP7 overexpression did not affect tumor growth <i>in vivo</i>.<h4>Conclusions</h4>SENP7 inhibits GBM invasion by dissociating proteins associated with tumor invasion from SUMO2/3, providing a potential target for future GBM therapies.